The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer

European Journal of Nuclear Medicine

Volumn 24, Issue 9, 1997, Pages 1175-1178

  Cwikla, J B ^a   Buscombe, J R ^a   Barlow, R V ^a   Kelleher, S M ^a   Parbhoo, S P ^a   Crow, J ^a   Deery, A ^a   Jones, A L ^a   Hilson, A J W ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

99mTc sestamibi; Breast cancer; Chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATIENT MONITORING; SCINTISCANNING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GENES, MDR; HUMANS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS;

EID: 0030801201     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050140     Document Type: Article

References (16)

1. Kao CH, Wang SJ. Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintgraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21: 432-436.
2. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg 1994; 178: 491-497.
3. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. Technetium-99m sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
4. Palmedo H, Schomburg A, Grunwald F, Mallman P, Krebs D, Biersak HJ. Technetium-99m scintimammography for suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
5. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrite J. Technetium-99-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
6. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996; 23: 940-946.
7. Tiling R, Sommer H, Pechman M, et al. Comparison of technetium-99m-sestamibi scintimammography with contrast enhanced MRI for diagnosis of breast lesions. J Nucl Med 1997; 36: 58-61.
8. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug resistance P glycoprotein transport function with an organotechnetium cation. Biochemistry 1995; 34: 12 210-12 229.
9. Herman LW, Sharma V, Kronauge JF, Barbaries E, Herman LA, Piwnica-Worms D. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. J Med Chem 1995; 38: 2955-2963.
10. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Cropy JM. Functional imaging of multidrug-resistance P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
11. m sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995, 16:253-257.
12. Moretti JL, DuranCordobes M, deBeco V, Boissier B, Kouyoumdji JC, Chevillard S, Starzec S. Tc-99m sestaMIBI uptake in human cancer cell lines resistant to chemotherapy mediated by multidrug resistance associated protein (MRP). J Nucl Med 1996; 37, 233P.
13. Sugawara I, Satake S, Wanatabe M, et al. Tumor imaging of multi-drug resistant cancers with organotechnetium complex. Tumor Targ 1996; 2: 224-229.
14. Linn SC, Giaccone G, van Deist PJ, et al. Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 1995; 6: 679-685.
15. Diggles L, Mena I, Khalkhali I. Technical aspects of prone dependent-breast scintigraphy. J Nucl Med Techol 1994; 22: 165-170.
16. Lastoria S, Varella P, Thomas R, et al. Predicting and monitoring the treatment in breast cancer by scintimammography with Tc-99m MIBI. J Nucl Med 1996, 37, 156P.